BlackRock’s Eli Lilly LLY Stock Holding History

BlackRock’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$104M	Buy	+113,000	New	+$115M	﹤0.01%	2087
2025 Q3	–	Sell	-95,400	Closed	-$74.4M	–	5533
2025 Q2	$74.4M	Buy	95,400 +56,200	+143%	+$43.7M	﹤0.01%	2234
2025 Q1	$32.4M	Buy	+39,200	New	+$32.6M	﹤0.01%	2633
2024 Q3	–	Sell	-82,500	Closed	-$74.7M	–	5282
2024 Q2	$74.7M	Sell	82,500 -44,200	-35%	-$35.4M	﹤0.01%	2204
2024 Q1	$98.6M	Buy	+126,700	New	+$90.2M	﹤0.01%	2057
2023 Q4	–	Sell	-183,000	Closed	-$98.3M	–	5426
2023 Q3	$98.3M	Buy	183,000 +32,200	+21%	+$16.6M	﹤0.01%	1994
2023 Q2	$70.7M	Buy	+150,800	New	+$63.2M	﹤0.01%	2280
2023 Q1	–	Sell	-378,700	Closed	-$139M	–	5650
2022 Q4	$139M	Sell	378,700 -194,400	-34%	-$68.9M	﹤0.01%	1787
2022 Q3	$185M	Buy	573,100 +30,000	+6%	+$9.51M	0.01%	1534
2022 Q2	$176M	Buy	+543,100	New	+$163M	0.01%	1617
2022 Q1	–	Sell	-244,500	Closed	-$67.5M	–	5872
2021 Q4	$67.5M	Buy	244,500 +110,700	+83%	+$28.1M	﹤0.01%	2456
2021 Q3	$30.9M	Buy	+133,800	New	+$33M	﹤0.01%	2991

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock's LLY Position: Q1 2026 in Review

BlackRock reduced its Eli Lilly (LLY) stake by 0.62% in Q1 2026, selling an estimated $418M and leaving 66,380,842 shares worth $61.1B. The position accounts for 1.07% of the portfolio, ranked #11.

BlackRock first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $71.8B in Q4 2025. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

BlackRock held 66,380,842 shares of Eli Lilly worth $61.1B as of Q1 2026.
BlackRock sold 412,021 Eli Lilly shares in Q1 2026, an estimated $418M.
Eli Lilly made up 1.07% of BlackRock's portfolio in Q1 2026, its #11 holding.
BlackRock first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
BlackRock's Eli Lilly position peaked at $71.8B in Q4 2025.
4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.